Pretty quiet out for one of the most significant milestones. Looks like after a couple months of planning we will be dosing people as soon as May. This is exciting because it reversed fibrosis in mice. AKA cured them. Right now people have to wait for a liver transplant take rejection drugs, and have to undergo a risky and painful operation. VS take a drug and get cured - oh and no side effects. Remember what carboydrates break down into - Thats right CO2 and H20. Doubt we will see any toxic side effects - didnt see it in DAVANAT won't see it here. It looks like they have an investigator lined up to run the study and if you look at the recent filing. They are pretty much paying as they go. You got to love how they put this together.
Considering the importance of this milestone, I too, am surprised the stock price hasn't jumped up into the + $4.00 price range at the minimum.......I'm also surprised the VOLUME of shares traded isn't a lot more.